跳至主要内容
临床试验/NCT06624709
NCT06624709招募中不适用

The Benefit in Terms of Improvement in Haemoglobin Level at 6 Months in Premature Babies Receiving Alternate Iron Substitution 4 Times a Week Compared to a Daily Substitution

Riccardo Pfister2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2024年11月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
160
试验地点
2
主要终点
Anemia at 6 months

研究概览

简要总结

BienFer is a double-blinded randomized controlled trial about iron substitution and abdominal pain. Premature babies and low birth weight babies have lower iron stores than term newborns and are therefore at greater risk of iron deficiency and anemia. Iron deficiency could have consequences for cerebral development. Ferric substitution reduces the risk of iron deficiency and anemia. It is common to replace premature babies with iron substitution between 2 weeks and 6 months of life. In practice, the medical staff notice that newborn with iron substitution have abdominal pain and constipation. A study in the adult population shows that alternate iron supplementation versus daily supplementation improved iron absorption, with no difference in hemoglobin level and decrease abdominal pain. Studies in children shows that intermittent iron supplementation do not change hemoglobin and ferritin level and improve adherence. There is no data comparing daily versus alternate supplementation in premature babies.

The aim of the study is to evaluate if alternate (4 times/week) iron supplementation is equivalent to daily iron substitution for hemoglobin values in premature babies between 28 0/7 weeks amenorrhea (WA) and 34 6/7 WA, and if it reduces abdominal discomfort and inflammation, and if it improves compliance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
14 Days 至 14 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Premature babies between 28 0/7WA and 34 6/7 WA
  • Parental consent, postnatal
  • Age of 2 weeks

排除标准

  • anemia < 80g/l at 2 weeks of age
  • Intraventricular Hemorrhage stage III and IV
  • Necrotizing Enterocolitis
  • Enteral feeding less than 100ml/kg/j after 2 weeks of life
  • Congenital disorder

研究组 & 干预措施

Alternate (4 times/week) iron supplementation

Active Comparator

This arm will receive 2-3mg/kg/d of maltofer 4 times a day

干预措施: Iron Supplement (Drug)

Daily iron substitution

Sham Comparator

This arm will receive 2-3mg/kg/d of maltofer 7 times per week.

干预措施: Iron Supplement (Drug)

结局指标

主要结局

Anemia at 6 months

时间窗: 6 months

Hemoglobin level

次要结局

  • Anemia(at 2weeks, 1 month, 2-3 months)
  • Ferritin(at 2 weeks, 1 month, 2-3 months and 6 months)
  • Evaluation of abdominal inflammation(at 2 weeks and 2-3 months)
  • Evaluation of intestinal microbiota(at 2-3 months)
  • Ret-Hb level(at 2 weeks, 1 month, 2-3 months and 6 months)
  • Transfusion(at 1 month, 2-3 months and 6 months)
  • Therapeutic level(at 1 month, 2-3 months and 6 months)
  • Comorbidities(at 6 months)
  • Evaluation of weight gain(at 2 weeks, 1 month, 2-3 months and 6 months)
  • Evaluation of height gain(at 2 weeks, 1 month, 2-3 months and 6 months)
  • Evaluation of the growth's parameter(at 2 weeks, 1 month, 2-3 months and 6 months)
  • Evaluation of abdominal discomfort(3 times per day during hospitalization then 1 time per 2 weeks until 6 months)

研究者

发起方
Riccardo Pfister
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Riccardo Pfister

Head of neonatology department, Principal Investigator, Clinical Professor

University Hospital, Geneva

研究点 (2)

Loading locations...

相似试验